Get the Stockscreener App
472.35
0.68%
3.17
After Hours:
473.16
0.81
+0.17%
Idexx Laboratories Inc stock is traded at $472.35, with a volume of 420.16K.
It is up +0.68% in the last 24 hours and up +0.63% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$469.18
Open:
$469.78
24h Volume:
420.16K
Relative Volume:
0.85
Market Cap:
$38.88B
Revenue:
$3.78B
Net Income/Loss:
$845.63M
P/E Ratio:
48.20
EPS:
9.8
Net Cash Flow:
$838.95M
1W Performance:
-1.87%
1M Performance:
+0.63%
6M Performance:
-15.27%
1Y Performance:
-3.20%
1-Day Range:
$467.31
$477.53
1-Week Range:
$465.53
$481.88
52-Week Range:
$372.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Victory Capital Management Inc. Trims Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects? - Yahoo Finance
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Bought by EFG Asset Management Americas Corp. - MarketBeat
Arcadia Investment Management Corp MI Grows Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
Why Is Idexx (IDXX) Up 0.9% Since Last Earnings Report? - Yahoo Finance
Commonwealth Equity Services LLC Trims Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Fortis Capital Advisors LLC Purchases Shares of 1,827 IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing? - Yahoo Finance
Summit Financial LLC Takes $650,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Holdings Raised by Van ECK Associates Corp - MarketBeat
Claro Advisors LLC Lowers Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Spire Wealth Management - MarketBeat
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Sells 70,670 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Allspring Global Investments Holdings LLC Has $16.49 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Allspring Global Investments Holdings LLC Lowers Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
Here’s Why IDEXX Laboratories (IDXX) Detracted in Q2 - MSN
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Kintegral Advisory LLC - MarketBeat
Do Options Traders Know Something About IDEXX (IDXX) Stock We Don't? - Yahoo Finance
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? - Inkl
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb Or Sink? - Barchart
Bank of New York Mellon Corp Cuts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Investors Shouldn't Overlook The Favourable Returns On Capital At IDEXX Laboratories (NASDAQ:IDXX) - Yahoo Finance
WD Rutherford LLC Reduces Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
New York State Teachers Retirement System Has $39.37 Million Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
A Look At The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Yahoo Finance
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference - 01Net
IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market - MarketWatch
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference - Business Wire
Council approves economic incentives for IDEXX - Restoration NewsMedia
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives $582.25 Average Price Target from Analysts - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing? - Simply Wall St
Ninety One UK Ltd Has $16.08 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories (MEX:IDXX) Enterprise Value : MXN774,562 Mil (As of Aug. 19, 2024) - GuruFocus.com
IDEXX Laboratories Inc. stock rises Monday, still underperforms market - MarketWatch
Sumitomo Mitsui Trust Holdings Inc. Sells 15,727 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Sumitomo Mitsui Trust Holdings Inc. - Defense World
IDEXX Laboratories (WBO:IDXX) Free Cash Flow : €777 Mil (TTM As of Jun. 2024) - GuruFocus.com
IDEXX Laboratories (XTER:IX1) 3-Year Revenue Growth Rate : 11.80% (As of Jun. 2024) - GuruFocus.com
IDEXX Laboratories (LTS:0J8P) 3-Year EBITDA Growth Rate : 16.70% (As of Jun. 2024) - GuruFocus.com
IDEXX Laboratories (LTS:0J8P) Enterprise Value : $41,182 Mil (As of Aug. 18, 2024) - GuruFocus.com
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Decreases By 8.6% - MarketBeat
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Decreases By 8.6% - Defense World
IDEXX Laboratories (WBO:IDXX) Profitability Rank : 10 (As of Jun. 2024) - GuruFocus.com
IDEXX Laboratories (WBO:IDXX) 3-Year EBITDA Growth Rate : 16.70% (As of Jun. 2024) - GuruFocus.com
IDEXX Laboratories (XTER:IX1) Inventory-to-Revenue : 0.38 (As of Jun. 2024) - GuruFocus.com
IDEXX Laboratories (STU:IX1) Momentum Rank : 5 (As of Aug. 17, 2024) - GuruFocus.com
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):